1986 Medical Degree - Medical College Of Wisconsin
Residency:
1988 Radiation Oncology, Columbia-Presbyterian
Medical Center
1990 Radiation Oncology, Washington University
School of Medicine, St. Louis, MO.
Hospital Affiliations:
Barnes-Jewish Hospital
Barnes-West County
St. Louis Children's Hospital
John Cochran VA Medical Center
Editorial Responsibilities:
International Journal of Radiation Oncology Biology, Physics, Editorial
Board, 1998
Radiologic Society of North America, Education Committee, Reviewer, 1998
Journal Articles:
Michalski JM, Winter K, Purdy JA, Parliament M, Wong H, Perez CA, Roach
M, Bosch W, Cox JD. Toxicity after three-dimensional radiotherapy for prostate
cancer on RTOG 9406 dose level V. Int J Radiat Oncol Biol Phys, 62(3):706-713,
July 2005.
Michalski JM, Meza J, Breneman JC, Wolden SL, Laurie F, Jodoin MA, Raney
B, Wharam M, Donaldson SS. Influence of Radiation Therapy Parameters on
Outcome in Children Treated with Radiation Therapy for Localized Parameningeal
Rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group Trials II through
IV. Int J Radiat Oncol Biol Phys, 59(4), 1027-1038, 2004.
Michalski JM, Winter K, Purdy J, Perez CA, et al. Toxicity following
3D radiation therapy for prostate cancer on RTOG 9406 dose level IV. Int
J Radiat Oncol Biol Phys, 58(3), 735-742, 2004.
Michalski J, Mutic S, Eichling J, Ahmed S N. Radiation Exposure to Family
and Household Members after Prostate Brachytherapy. Int J Radiat Oncol Biol
Phys 56(3), 764-768, 2003.
Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, Parliament
MB, Pollack A, Markoe AM, Harms W, Sandler HM, Cox JD. Preliminary Evaluation
of Low-Grade Toxicity with Conformal Radiation Therapy for Prostate Cancer
on RTOG 9406 Dose Levels I and II. Int J Radiat Oncol Biol Phys 56(1), 192-198,
2003.
Michalski JM, Winter K, Purdy JA, Wilder R, Perez CA, Roach M, Parliament
M, Pollack A, Markoe A, Harms WB, Sandler H, Cox JD. Trade-off to low-grade
toxicity with conformal radiation therapy for prostate cancer on Radiation
Therapy Oncology Group 9406. Semin Radiat Oncol 2002 Jan; 12(1 Suppl 1):75-80
Purdy JA, Michalski JM. Does the evidence support the enthusiasm over
3D conformal radiation therapy and dose escalation in the treatment of prostate
cancer? Int J Radiat Oncol Biol Phys 2001 Nov 15; 51(4):867-70
Perez CA, Michalski JM, Purdy JA, Wasserman TH, Williams K, Lockett MA.
Three-dimensional conformal therapy or standard irradiation in localized
carcinoma of prostate: preliminary results of a nonrandomized comparison.
Int J Radiat Oncol Biol Phys 2000; 47(3):629-37
Krumholtz JS, Michalski JM, Surndaram CP. Health-related quality of life
and morbidity in patients receiving brachtherapy for clinically localized
prostate cancer. J Endourol 2000; 14(4):371-4
Michalski JM, Purdy JA, Winter K, Roach M, Vijayakumar S, Sandler HM,
Markoe A, Ritter MA, Russell KJ. Sailer S. Harms WB, Perez CA, Hanks GE,
Cox JD: Preliminary report of toxicity following 3D radiation therapy for
prostate cancer on 3DOG/RTOG 9406, Int J Radiat Oncol Biol Phys, 2000; 46(2):391-402
Michalski JM, Purdy JA. Innovations in three-dimensional treatment planning
and quality assurance. Tumori, 1998; 84(2):127-139
Tinger A, Michalski JM, Cheng A, Low DA, Zhu R, Bosch WR, Purdy JA, Perez
CA. A critical evaluation of the planning target volume for 3-D conformal
radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys, 1998; 42(1):213-221
Diamond DA, Michalski JM, Lynch JP, Trulock EP. Efficacy of total lymphoid
irradiation for chronic allograft rejection following bilateral lung transplantation.
Int J Radiat Oncol Biol Phys, 1998; 41:795-800
Kobeissi B, Gupta M, Perez CA, VanAntwerp G, Michalski JM, Dopuch N, Gerber
R, Wasserman T: Physician resource utilization in radiation oncology: A
model based on management of carcinoma of the prostate. Int J Radiat Oncol
Biol Phys, 1998; 40(3): 593-603
Vijayakumar S, Winter K, Sause W, Gallagher MJ, Michalski J, Roach M,
Porter A, Bondy M: Prostate-specific antigen levels are higher in African-American
than in white patients in a national registration study: Results of RTOG
94-12. Int J Radiat Oncol Biol Phys, 1998; 40:17-25
Perez CA, Michalski JM, Ballard S, Drzymala R, Kobeissi BJ, Lockett MA,
Wasserman TH. Cost benefit of emerging technology in localized carcinoma
of the prostate. Int J Radiat Oncol Biol Phys, 1997; 39:875-83
Yan D, Wong J, Vicini F, Michalski J, Pan C, Frazier A, Horwitz E, Martinez
A: Adaptive modification of treatment planning to minimize the deleterious
effects of treatment setup errors. Int J Radiat Oncol Biol Phys, 1997; 38:197-206
Perez CA, Michalski J, Brown KC, Lockett MA: Nonrandomized evaluation
of pelvic lymph node irradiation in localized carcinoma of the prostate.
Int J Radiat Oncol Biol Phys, 1996; 36:573-584
Michalski JM, Purdy JA, Harms WB, Matthews JW. The CT-simulation 3D treatment
planning process. Front Radiat Ther Oncol, 1996; 29:43-56
Bosch W, Michalski JM, Purdy JA: Radiation Oncology Picture Archiving
and Communications System: The electronic viewbox. Front Radiat Ther Oncol,
1996; 29:168-179
Michalski JM, Graham MV, Bosch WR, Wong J, Gerber RA, Cheng A, Tinger
A, Valicenti R. Prospective clinical evaluation of an electronic portal
imaging device. Int J Radiat Oncol Biol Phys, 1996; 34:943-51
Tinger A, Michalski JM, Bosch WR, Valicenti RK, Low DA, Myerson RJ. An
analysis of intratreatment and intertreatment displacements in pelvic radiotherapy
using electronic portal imaging. Int J Radiat Oncol Biol Phys, 1996; 34:683-690
Perez CA, Michalski JM, Lockett MA. Radiation therapy in the treatment
of localized prostate cancer: An alternative to an emerging consensus. Missouri
Medicine, November, 1995; pp. 696-704
Valicenti RK, Michalski JM, Bosch WR, Gerber R, Graham MV, Cheng A, Purdy
JA, Perez CA. Is weekly port filming adequate for verifying patient position
in modern radiation therapy? Int J Radiat Oncol Biol Phys 1994; 30(2):431-8
